KLEIN; Michel

Patent Applications and Registrations

Patent applications and USPTO patent grants for KLEIN; Michel.The latest application filed is for "immune composition, preparation method therefor, and application thereof".

Company Profile

0.12.9

KLEIN; Michel - Wuhan CN
KLEIN; MICHEL - EINDHOVEN NL
Klein; Michel - Zaandijk NL
Klein; Michel - Willowdale CA
Klein, Michel - La Tour de Salvagny FR
KLEIN, MICHEL - LYON CEDEX FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Immune Composition, Preparation Method Therefor, And Application Thereof App 20210290759 - MU; Ting ; et al.	2021-09-23
Messaging System App 20180277013 - VAN HALTEREN; AART TIJMEN ; et al.	2018-09-27
Generation of new BCG vaccine strains protecting against the establishment of latent Mycobacterium tuberculosis infection and reactivation from the latent or persistent state Grant 7,935,354 - Flores-Valdez , et al. May 3, 2	2011-05-03
Generation Of New Bcg Vaccine Strains Protecting Against The Establishment Of Latent Mycobacterium Tuberculosis Infection And Reactivation From The Latent Or Persistent State App 20090123492 - Flores-Valdez; Mario Alberto ; et al.	2009-05-14
Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines Grant 7,018,637 - Chong , et al. March 28, 2	2006-03-28
Use of lipopeptides in immunotherapy of HIV+ individuals App 20040058861 - Caudrelier, Pierre ; et al.	2004-03-25
Vaccination of hiv infected persons following highly active antiretrovial therapy App 20040034209 - Ho, David ; et al.	2004-02-19
Mutated HIV Tat App 20040005330 - Rappaport, Jay ; et al.	2004-01-08
Purification Of A Pertussis Outer Membrane Protein App 20020015711 - JACKSON, GAIL ; et al.	2002-02-07
Purification of a pertussis outer membrane protein App 20010051163 - Jackson, Gail ; et al.	2001-12-13
Novel Multi-oligosaccharide Glycoconjugate Bacterial Meningitis Vaccines App 20010048929 - CHONG, PELE ; et al.	2001-12-06
Transferrin receptor genes Grant 6,262,016 - Loosmore , et al. July 17, 2	2001-07-17
Transferrin receptor genes Grant 6,015,688 - Loosmore , et al. January 18, 2	2000-01-18
Transferrin receptor antibodies Grant 6,008,326 - Loosmore , et al. December 28, 1	1999-12-28
Transferrin receptor genes and immunogenic compositions derived therefrom Grant 5,922,323 - Loosmore , et al. July 13, 1	1999-07-13
Recombinantly produced transferrin receptor of haemophilus Grant 5,922,841 - Loosmore , et al. July 13, 1	1999-07-13
Synthetic eukaryotic promoters containing two inducible elements Grant 5,877,018 - Filmus , et al. March 2, 1	1999-03-02
Synthetic peptides for an HIV-1 vaccine Grant 5,817,318 - Sia , et al. October 6, 1	1998-10-06
Method for producing purified recombinant Haemophilus influenzae transferrin binding proteins Grant 5,708,149 - Loosmore , et al. January 13, 1	1998-01-13
Synthetic Haemophilus influenzae conjugate vaccine Grant 5,679,352 - Chong , et al. October 21, 1	1997-10-21
Purification of a pertussis outer membrane protein Grant 5,667,787 - Jackson , et al. September 16, 1	1997-09-16

Company Registrations

CAGE Code

L6505

KLEIN, MICHEL

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.